$[Translated article] Anifrolumab for the Treatment of Refractory Cutaneous Lupus Erythematosus: A Spanish Clinical Practice-Based Multicenter Study$

[Translated article] Anifrolumab for the Treatment of Refractory Cutaneous Lupus Erythematosus: A Spanish Clinical Practice-Based Multicenter Study

Saved in:

Bibliographic Details
Main Authors:	D. Martín-Torregrosa, M. Mansilla-Polo, A. Grau-Echavarría, V. Zaragoza-Ninet, N. Jara-Rico, R. Alcalá-García, I. Torres-Navarro, R. Botella-Estrada
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Actas Dermo-Sifiliográficas
Online Access:	http://www.sciencedirect.com/science/article/pii/S0001731025001401
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anifrolumab para el tratamiento del lupus eritematoso cutáneo refractario: estudio multicéntrico español en la práctica clínica
by: D. Martín-Torregrosa, et al.
Published: (2025-05-01)

Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report
by: Abdullah Ramadhan, et al.
Published: (2025-06-01)

Successful treatment of recalcitrant cutaneous lupus erythematosus with anifrolumab in patients without systemic lupus erythematosus
by: Bishoy Abdelmalik, BS, et al.
Published: (2025-01-01)

Flare of bullous lupus erythematosus in patients treated with anifrolumab for discoid lupus erythematosus: 2 cases
by: Cécile Lesort, MD, et al.
Published: (2025-04-01)

Experience of using Anifrolumab in the treatment of patients with systemic lupus erythematosus
by: E. V. Bolotova, et al.
Published: (2025-03-01)

Rapid resolution of fever and panniculitis after anifrolumab in a patient with systemic lupus erythematosus refractory to standard immunosuppression
by: Shunichiro Hanai, et al.
Published: (2025-08-01)

Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report
by: Gabriela Soto-Canetti, MPH, et al.
Published: (2025-06-01)

The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
by: Fulvia Ceccarelli, et al.
Published: (2025-07-01)

Hypertrophic lupus erythematosus hypertrophic lichen planus overlap responding to acitretin and anifrolumab
by: Roxana A. Hojjatie, BS, et al.
Published: (2025-05-01)

[Translated article] Cutaneous Sarcoidosis after Platelet-Rich Plasma Injections and Permanent Eyebrow Make-Up
by: D. Martín-Torregrosa, et al.
Published: (2024-11-01)

Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
by: Ryan Bonaventure Soares, et al.
Published: (2025-01-01)

Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
by: T. M. Reshetnyak, et al.
Published: (2023-12-01)

Post-marketing safety signals of anifrolumab in systemic lupus erythematosus: a pharmacovigilance study based on FAERS
by: Yuzhe Cheng, et al.
Published: (2025-07-01)

Acute Cutaneous Lupus Erythematosus
by: K. C. Manish, et al.
Published: (2021-10-01)

Real-world effectiveness of belimumab and anifrolumab in systemic lupus erythematosus: comparable trends in disease activity and glucocorticoid reduction
by: Ryota Sato, et al.
Published: (2025-07-01)

New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)
by: E. L. Nasonov, et al.
Published: (2021-10-01)

Isoniazid - induced chronic cutaneous Lupus erythematosus
by: A Chiriac, et al.
Published: (2016-01-01)

Isoniazid - induced chronic cutaneous Lupus erythematosus
by: A Chiriac, et al.
Published: (2016-01-01)

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)
by: T. M. Reshetnyak, et al.
Published: (2024-04-01)

Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study
by: Marta Mosca, et al.
Published: (2024-11-01)

Herbal microsponge gel for the treatment of cutaneous lupus erythematosus
by: Sweety Chheda, et al.
Published: (2025-06-01)

Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital
by: M. Mansilla-Polo, et al.
Published: (2024-11-01)

Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol
by: María Galindo-Izquierdo, et al.
Published: (2025-02-01)

Position on the use of anifrolumab in patients with systemic lupus erythematosus with insufficient efficacy of standard therapy in real-life clinical practice. Comments from Russian experts
by: E. A. Aseeva, et al.
Published: (2024-06-01)

Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus
by: Benjamin A Nanes, et al.
Published: (2020-10-01)

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report
by: Chenxi Zhang, et al.
Published: (2025-04-01)

A striking case of cutaneous adult T-cell leukemia/lymphoma mimicking subacute cutaneous lupus erythematosus
by: Daniel S. Alicea, MS, et al.
Published: (2025-08-01)

Can Dermoscopy Be a Useful Follow-Up Tool in Patients with Discoid Lupus Treated with Anifrolumab?
by: Francesca Ambrogio, et al.
Published: (2025-02-01)

Recalcitrant Dermatomyositis Treated With Anifrolumab
by: Shivang Chaudhary, et al.
Published: (2025-01-01)

Prevalence of cutaneous warts in patients with systemic lupus erythematosus: a systematic review
by: Luisa Moreira Silva, et al.
Published: (2016-09-01)

Adalimumab‐Induced Cutaneous Lupus Erythematosus: Cases Presenting With Malar Rash and Panniculitis
by: Parvin Mansouri, et al.
Published: (2025-01-01)

Neonatal lupus erythematosus: Report of a case with cutaneous, hematological and hepatobiliary findings
by: Andaç Salman, et al.
Published: (2016-02-01)

WCN24-420 SAFETY AND EFFICACY OF ANIFROLUMAB IN IMMUNE COMPLEX AND APOL-1 ASSOCIATED LUPUS PODOCYTOPATHY
by: James Tumlin, et al.
Published: (2024-04-01)

Clinical, Histopathological, and Therapeutic Features in Lupus Erythematosus Tumidus: A Retrospective Study
by: E. La Rotta-Higuera, et al.
Published: (2025-06-01)

Ocular Complications in Cutaneous Lupus Erythematosus: A Systematic Review with a Meta-Analysis of Reported Cases
by: L. Arrico, et al.
Published: (2015-01-01)

The role of UV-induced cutaneous matrix metalloproteinases and mi-RNAs in the pathogenesis of lupus erythematosus
by: I. Ivanova, et al.
Published: (2025-06-01)

Apoptosis and Redistribution of the Ro Autoantigen in Balb/c Mouse Like in Subacute Cutaneous Lupus Erythematosus
by: Rafael Herrera-Esparza, et al.
Published: (2006-01-01)

Fatal CMV-Infection after Autologous Stem Cell Transplantation in Refractory Systemic Lupus Erythematosus
by: László Váróczy, et al.
Published: (2012-01-01)

RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
by: Joseph F Merola, et al.
Published: (2021-04-01)

EXANTHEMATOUS LUPUS ERYTHEMATOSUS
by: N.S. Podchernyaeva, et al.
Published: (2006-12-01)